Stefan Ries
Company: DISCO Pharmaceuticals
Job title: Chief Scientific Officer, R&D
Seminars:
Discovering Novel Target Combinations for Bispecific ADCs to Increase Cancer Selectivity 3:15 pm
Identifying cell surface proteins for bispecific targeting of cancer cells Outlining benefits of utilizing bispecific ADCs to increase the therapeutic index Unique challenges to overcome when designing bispecific ADCsRead more
day: Conference Day One